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Background
•
Frailty is a multiply determined, increased vulnerability to a range of adverse health outcomes.
• It is associated with falls, CI, disability, hospitalization, institutionalization and death as well as adverse responses to chemotherapy and surgical intervention.
• Frailty was demonstrated to be the most common chronic condition leading to death in older adults.
• Researchers do not agree on what "frailty" means, or on how to measure it.
• Gold standard assessment -thoughtful clinician assessment • Scale models vary based on definition of frailty that is used:
• "Biological syndrome resulting from cumulative decline across multiple physiological systems" to "Multidimensional risk state that can be measured more by the quantity than by the nature of health problems" • The assessment of frailty is important for clinical care, research, and policy planning.
Goals of the Study
• Compare eight proposed frailty scales for their content validity, feasibility, prevalence estimates, and ability to predict all cause mortality. • Attempt to "operationalize" frailty so that it can be more accurately assessed/identified.
Methods Review
• Population chosen -Eleven European countries, individuals in the community age 50-104, mean of 65. 
Measurements
The SHARE data base was run on each of the following scales:
• Groningen Frailty Indicator, Tilburg Frailty Indicator, 70 item Frailty Index (FI), 44 item Frailty, Index based on a Comprehensive Geriatric Assessment (FI-CGA), Clinical Frailty Scale, Frailty phenotype (weighted and un-weighted versions), The Edmonton Frail Scale, The FRAIL scale
• The scales measure deficits in various domains including: mobility, nutrition, weight loss, mental health, ADLs, energy/exhaustion, strength, speed ,cognition, polypharmacy, social support, psychosocial, "health status", self-rated health, behavioral risks • Each scale was assigned a score threshold that would represent the "frailty" state or diagnosis Missing Data/Changing Data
• Making pre-existing data base fit 8 different scales
• Different techniques used -exclusion of participants with >20% of missing scale items, imputation of 0's for missing data at total of less than 20% items • Clinical Frailty Scale -participants were excluded if they had any missing scale item • No substitution procedure was required for the FI and FI-CGA Outcomes: Prevalence of Frailty and Prediction of All-cause Mortality
• The prevalence of frailty was calculated for each scale based on score cut-points.
• Agreement among scales was examined using the Cohen Kappa statistic.
• The accuracy of each scale to predict all-cause mortality was assessed by comparing AUC (ROC curves) • Calibration weights were used to reflect the size of the national population according to age and sex.
Results/Discussion
• All scales had fewer than 6% of cases with at least one missing item, except the Frailty phenotype (11.1%) and the Tilburg (12.2%) • 9.7% of participants were missing data for the grip strength, 61% of whom had been unable to complete the test. • In the Groningen, Tilburg, frailty phenotype, and FRAIL scales, death rates were 3-5x as high in excluded cases as in included ones.
• Frailty prevalence estimates ranged from 6% (FRAIL) to 44% (Groningen).
• Approximately half of participants (51%) were categorized as frail or non-frail identically in all scales (49% non-frail and 2.4% frail).
• 6/8 scales identified 76% of participants consistently as non-frail and 9% consistently as frail.
• The lowest agreement was between the Groningen and FRAIL scales.
• The AUC for mortality ranged from 0.67 (FRAIL) and 0.77 (FI) and 0.79 (95% CI=0.77-0.81) (weighted frailty phenotype) • Of un-weighted scales, the FI and Edmonton scales most accurately predicted mortality at 2 (FI AUC=0.77, 95% Cl 0.75-0.79; Edmonton AUC=0.76, 95% CI = 0.74-0.79) and 5 (AUC=0.75, 95% CI = 0.74-0.77) years
Conclusions
• Content validity was evaluated in relation to the multidimensionality that each instrument assayed.
• The feasibility of each scale was examined according to the number of excluded cases due to missing variables.
• Excluded case having higher mortality rate could be meaningful.
• Different scales estimated widely different values for the prevalence of frailty.
• These frailty scales capture related but distinct groups.
• The frailty index seems to be a feasible scale that captures the multidimensionality of frailty and has high predictive ability.
• Weighting items in frailty scales can improve their predictive ability, but the trade-off between specificity, predictive power, and generalizability requires additional evaluation.
Limitations
• Questionable if it accomplished goals of evaluating content validity and feasibility • Hard to understand where the frailty "cut point" comes from.
• Limited explanation of how data manipulation was done • Scales' criteria modified to fit data available from SHARE data -Some scales were closer to the original scales than others -Different exclusion criteria • Not sure all these scales should be compared • Frailty scales that are missing certain data, excluded participants frailer than the rest of the population, indicating a potential selection bias in the use of these scales • European population, low starting age, did not further break down prevalence/mortality by age • ?Conflicts of interest
Practice implications
• Better understanding of the factors that are associated with frailty will improve clinical assessment of frailty • Strengthen decisions to encourage/discourage interventions • Frailty Index seems like a fairly easy scale to try on continuity patient -many of the components would be easily remembered or retrieved
